By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ness Ziona      Israel
Phone: Fax:



Start Up

Company News
Israeli Biotech Foamix Files For A $75 Million IPO 8/14/2014 11:16:15 AM
Foamix To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention On June 26th In San Diego 6/18/2014 9:16:41 AM
Foamix Establishes U.S. Subsidiary And Strengthens Executive Management With Appointment Of Senior U.S. Leadership Team 6/12/2014 7:23:18 AM
Foamix Announces Collaboration With National Institutes of Health (NIH) 6/3/2014 9:22:00 AM
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014 9:17:18 AM
Foamix To Present At The 34th Annual Cowen and Company Health Care Conference -- Successful Phase 2 For First Ever Topical Minocycline For Acne And Impetigo 2/27/2014 9:15:05 AM
Merz North America and Foamix to Develop an Innovative Medicated Foam 7/8/2013 10:21:50 AM
Superior Results in Foamix's Minocycline Foam Clinical Study: 71% Reduction in Inflammatory Lesions in 6 Weeks 6/11/2013 10:05:24 AM
Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment 6/4/2012 10:26:45 AM
Foamix's Minocycline Foam - 100% Effective in Impetigo Phase II Clinical Trial With No Side Effects - 80% Improved Significantly After 3 Days of Treatment 3/15/2012 6:33:02 AM